PeptiDream Inc (PPTDF)
13.11
+3.61
(+38.00%)
USD |
OTCM |
Apr 30, 16:00
PeptiDream Gross Profit Margin (Quarterly): 48.45% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 48.45% |
| September 30, 2023 | 78.28% |
| June 30, 2023 | 40.61% |
| March 31, 2023 | 43.30% |
| December 31, 2022 | 80.49% |
| September 30, 2022 | 58.33% |
| June 30, 2022 | 43.23% |
| March 31, 2022 | -18.12% |
| December 31, 2021 | 55.76% |
| September 30, 2021 | 85.27% |
| June 30, 2021 | 45.53% |
| March 31, 2021 | 62.96% |
| December 31, 2020 | 89.03% |
| September 30, 2020 | 43.13% |
| June 30, 2020 | 80.24% |
| March 31, 2020 | 13.97% |
| September 30, 2019 | 18.43% |
| June 30, 2019 | 83.63% |
| March 31, 2019 | 66.02% |
| December 31, 2018 | 75.85% |
| September 30, 2018 | 48.32% |
| Date | Value |
|---|---|
| June 30, 2018 | 87.21% |
| March 31, 2018 | -49.24% |
| December 31, 2017 | 53.62% |
| September 30, 2017 | -147.4% |
| June 30, 2017 | 80.94% |
| March 31, 2017 | 10.39% |
| December 31, 2016 | 37.31% |
| September 30, 2016 | 69.94% |
| June 30, 2016 | 74.14% |
| March 31, 2016 | 83.56% |
| December 31, 2015 | 68.00% |
| September 30, 2015 | 52.94% |
| June 30, 2015 | 81.85% |
| March 31, 2015 | 15.01% |
| December 31, 2014 | 51.90% |
| September 30, 2014 | 11.15% |
| June 30, 2014 | 63.25% |
| March 31, 2014 | 34.89% |
| December 31, 2013 | 74.22% |
| September 30, 2013 | 57.90% |
| June 30, 2013 | 52.93% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-18.12%
Minimum
Mar 2022
89.03%
Maximum
Dec 2020
52.92%
Average
52.11%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 65.85% |
| Nxera Pharma Co Ltd | 76.00% |
| Stemcell Holdings Inc | -- |
| Healios KK | -- |
| AnGes Inc | 14.39% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.41% |
| Return on Assets | 4.57% |
| Return on Invested Capital | 5.29% |
| Profit Margin (Quarterly) | -8.20% |
| Operating Margin (Quarterly) | 0.33% |
| Return on Net Operating Assets | 7.31% |